 Oral almitrine treatment acute respiratory failure cor pulmonale patients exacerbation chronic obstructive airways disease effects oral almitrine bismesylate respiratory stimulant peripheral arterial chemoreceptors patients chronic obstructive airways disease hypoxaemic cor pulmonale Twenty patients acute exacerbation ventilatory failure almitrine mg day mg day hours placebo addition conventional treatment admission mean SE values blood gas tensions kPa patients almitrine kPa placebo hours oxygen therapy similar rise groups kPa almitrine kPa placebo hours oxygen therapy values similar kPa kPa Arterial blood gas tensions study significant differences apparent groups deaths almitrine group placebo group differences groups respiratory rate results spirometry oxygen requirement degree dyspnoea visual analogue scale results benefit oral almitrine patients acute respiratory failure secondary obstructive airways disease Plasma almitrine concentrations optimum therapeutic range impaired drug absorption